Evaluation of Carotid Plaque Neovascularization in Patients With Coronary Heart Disease on Contrast-Enhanced Ultrasonography

2017 ◽  
Vol 37 (4) ◽  
pp. 823-831 ◽  
Author(s):  
Chuan Qin ◽  
Li Zhang ◽  
Xinfang Wang ◽  
Yilian Duan ◽  
Zhou Ye ◽  
...  
PLoS ONE ◽  
2008 ◽  
Vol 3 (10) ◽  
pp. e3435 ◽  
Author(s):  
Kuo-Liong Chien ◽  
Ta-Chen Su ◽  
Jiann-Shing Jeng ◽  
Hsiu-Ching Hsu ◽  
Wei-Tien Chang ◽  
...  

2020 ◽  
Author(s):  
Fang Yang ◽  
Cong Wang

AbstractThis meta-analysis aimed to identify the consistency of superb microvascular imaging(SMI) and contrast-enhanced ultrasonography(CEUS) in detecting intraplaque neovascularization(IPN). We searched PubMed, Web of Science, Cochrane Library, CISCOM, and CBM databases without language restrictions. Meta-analysis was conducted using STATA version 15.1 software. We calculated the pooled Kappa index. Ten studies that met all inclusion criteria were included in this meta-analysis. A total of 608 carotid plaques were assessed through both SMI and CEUS. The pooled summary Kappa index was 0.743(95 % CI=0.696-0.790) with statistical significance(z= 31.14, p<0.01). We found no evidence for publication bias (t=-1.21, p=0.261). Our meta-analysis indicates that SMI and CEUS display a good consistency in detecting IPN of carotid plaque, that is to say SMI ultrasound maybe a promising alternative to CEUS for detecting IPN of carotid plaque.


2009 ◽  
Vol 4 ◽  
pp. S106
Author(s):  
Kuo-Liong Chien ◽  
Ta-Chen Su ◽  
Jiann-Shing Jeng ◽  
Hsiu-Ching Hsu ◽  
Wei-Tien Chang ◽  
...  

2009 ◽  
Vol 16 (3) ◽  
pp. 147-154 ◽  
Author(s):  
David S Wald ◽  
Jonathan P Bestwick

Background Carotid artery ultrasound is a possible screening test for future coronary heart disease (CHD) events to select individuals for preventive treatment. Objectives To assess the screening performance of carotid artery intima-media thickness (IMT) and carotid plaque in the identification of individuals with CHD. Methods meta-analysis of case-control and cohort studies, reporting carotid IMT or plaque in individuals with and without CHD. Screening performance (detection rates [DRs] for specified false-positive rates [FPRs]) was assessed from the relative Gaussian distributions of IMT among individuals with and without CHD and from the proportion of affected and unaffected individuals with plaque. Results Eighteen studies, involving 2920 individuals with CHD (mean age range 46–73 years) and 41,941 without (aged 44–73 years) were included in the meta-analysis. For plaque the DR was 62% for an FPR of 30%; likelihood ratio (2.1 [95% CI 1.6–2.4]). For IMT, the DR was 65% for the same 30% FPR (IMT cut-off ≥0.82 mm); likelihood ratio 2.2 (1.9–2.5). The results were similar in case-control and cohort studies. Conclusion Neither carotid plaque nor IMT has a CHD screening performance that is sufficiently discriminatory between affected and unaffected individuals to be a worthwhile screening test.


2016 ◽  
Vol 11 (7) ◽  
pp. 791-798 ◽  
Author(s):  
Omi Hamada ◽  
Noriyuki Sakata ◽  
Toshiyasu Ogata ◽  
Hirofumi Shimada ◽  
Tooru Inoue

Sign in / Sign up

Export Citation Format

Share Document